Cynthia L Grosskreutz MD PhD
Associate Professor, Ophthalmology, Harvard Medical School
Join to View Full Profile
243 Charles StBoston, MA 02114
Dr. Grosskreutz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1990 - 1993
Steward Carney HospitalInternship, Internal Medicine, 1989 - 1990
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1989
Certifications & Licensure
MA State Medical License 1993 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- Multiparametric grading of glaucoma severity by histopathology can enable post-mortem substratification of disease state.Chuanxi Xiang, VijayKrishna Raghunathan, Yubin Qiu, Manisha Mehta, John T Demirs
Acta Neuropathologica Communications. 2025-01-06 - Patient-Reported Outcomes in RLBP1 Retinal Dystrophy: Longitudinal Assessment in a Prospective Natural History Study.James Whelan, Jane Green, Marie Burstedt, Erin Greco, Xiao Ni
Translational Vision Science & Technology. 2024-11-04 - 4 citationsInterim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial.Anders Kvanta, Nalini Rangaswamy, Karen Holopigian, Christine Watters, Nicki Jennings
Nature Communications. 2024-09-10
Press Mentions
Novartis : Acquires Arctos Medical, Expanding Optogenetics Portfolio to Bring Gene Therapies to Patients with Severe Vision LossSeptember 23rd, 2021- Gene Therapy, High-Tech Goggles Restore Some Vision to Blind PeopleMay 24th, 2021
- Week in Review: Corneal Shield, Novartis Acquisition, Preloaded IOLNovember 6th, 2020
Grant Support
- Neuroprotection And Retinal Ganglion Cell DeathNational Eye Institute2002–2010
- Hypoxic Regulation Of Vascular Growth In VitroNational Eye Institute1997–1998
- Hypoxic Regulation Of Vascular Growth In VitroNational Eye Institute1994–1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
